Euronext PSI20 (PSI20.NDX)

Close: 5 762.20 (+91.22), Oct 20, 2021
Positive

Automatic technical analysis. Medium term, Oct 20, 2021

Euronext PSI20 has broken the rising trend up in the medium long term. This signals an even stronger rate of growth, but the positive development may result in corrections down in the short term. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 5280 points. The short term momentum of the index is strongly positive, with RSI above 70. This indicates increasing optimism among investors and further price increase for Euronext PSI20. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.89%0.00+1.61%
5 days0.002.88%0.00+3.02%
22 days0.007.61%0.00+10.52%
66 days0.0015.31%0.00+17.60%

More analyses of Euronext PSI20

chart Euronext PSI20 (PSI20) Candlesticks 22 Days
Candlesticks
chart Euronext PSI20 (PSI20) Short term
Short term: Positive
chart Euronext PSI20 (PSI20) Medium term
Medium term: Positive
chart Euronext PSI20 (PSI20) Long term
Long term: Weak Negative
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK